Fatskills
Practice. Master. Repeat.
Study Guide: USMLE Step 3: Haematology, Oncology, Ambulatory Oncology, Screening, Survivorship, Palliative Care, Transitions, Follow-up
Source: https://www.fatskills.com/usmle/chapter/usmle-step-3-haematology-oncology-ambulatory-oncology-screening-survivorship-palliative-transitions-follow-up

USMLE Step 3: Haematology, Oncology, Ambulatory Oncology, Screening, Survivorship, Palliative Care, Transitions, Follow-up

By Fatskills Exam Guides Team — the exam nerds behind 28,500+ quizzes and 2.1M practice questions across 500+ global exams.

⏱️ ~4 min read

What This Is and Why It Matters for USMLE

Ambulatory Oncology: Screening, Survivorship, Palliative Transitions, and Follow-up is a high-yield topic for Step 1, Step 2 CK, and Step 3. It appears in basic science, clinical, and ethics/management contexts, with a focus on cancer diagnosis, treatment, and management.

High-Yield Facts (What You Must Memorize)

  • Pathophysiology: Cancer is a complex interplay of genetic mutations, epigenetic changes, and environmental factors.
  • Classic presentation and physical exam findings:
    • Breast cancer: new lump or mass, skin changes, nipple discharge.
    • Lung cancer: cough, weight loss, hemoptysis.
    • Colorectal cancer: change in bowel habits, rectal bleeding.
  • Diagnostic approach:
    • Labs: tumor markers (e.g., PSA, CA-125), complete blood count (CBC), liver function tests (LFTs).
    • Imaging: computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET).
  • First-line treatment and management:
    • Surgery: wide local excision, mastectomy, colectomy.
    • Chemotherapy: anthracyclines, taxanes, targeted therapy.
    • Radiation therapy: external beam radiation, brachytherapy.
  • Red flags, complications, and follow-up:
    • Metastasis, recurrence, second primary cancer.
    • Chemotherapy-induced side effects (e.g., neutropenia, nausea).
    • Follow-up appointments: regular check-ups, surveillance imaging, tumor marker monitoring.

Clinical Pearls & Buzzwords

  • HER2-positive breast cancer-trastuzumab.
  • EGFR mutations-tyrosine kinase inhibitors.
  • Microsatellite instability-immunotherapy.

Step-by-Step Clinical Reasoning

  1. Identify the syndrome or presentation (e.g., new lump, cough, change in bowel habits).
  2. Generate a differential (most likely and must-not-miss):
    • Breast cancer: ductal carcinoma in situ (DCIS), inflammatory breast cancer.
    • Lung cancer: adenocarcinoma, squamous cell carcinoma.
    • Colorectal cancer: adenocarcinoma, carcinoid tumor.
  3. Order appropriate initial tests:
    • Labs: CBC, LFTs, tumor markers.
    • Imaging: CT, MRI, PET.
  4. Interpret results:
    • Biopsy-histopathology.
    • Imaging-tumor size, metastasis.
  5. Initiate treatment and monitoring:
    • Surgery-wide local excision, mastectomy.
    • Chemotherapy-anthracyclines, taxanes.
    • Follow-up-surveillance imaging, tumor marker monitoring.

Missing a life-threatening complication (e.g., metastasis, recurrence) can lead to delayed treatment and poor outcomes.

Common Mistakes & Exam Traps

  • The mistake: Failing to consider metastasis in a patient with a new diagnosis of cancer.
  • Why it happens: Rushing through the exam and not considering all possible diagnoses.
  • How to avoid it: Take your time, consider all possible diagnoses, and order appropriate tests.
  • Exam board insight: The examiners will penalize you for missing a life-threatening complication.
  • The mistake: Not ordering surveillance imaging in a patient with a history of cancer.
  • Why it happens: Misunderstanding the importance of follow-up care.
  • How to avoid it: Understand the importance of follow-up care and order appropriate tests.
  • Exam board insight: The examiners will penalize you for not following up with a patient with a history of cancer.

How It’s Tested on USMLE

  • Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
  • Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain...").
  • Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

Note common distractors and NBME tricks: Distractor: Focusing on the wrong aspect of the patient's presentation (e.g., weight loss instead of cough). NBME trick: Using buzzwords (e.g., HER2-positive) to distract from the correct answer.

CCS (Step 3) Relevance (If Applicable)

If this topic appears in Step 3 Computer-based Case Simulations, provide a short strategy: Initial orders: + Complete blood count (CBC). + Liver function tests (LFTs). + Imaging studies (e.g., CT, MRI). Monitoring and follow-up: + Tumor marker monitoring. + Surveillance imaging. + Follow-up appointments. Common mistakes: + Not ordering indicated tests (e.g., biopsy). + Delaying treatment (e.g., chemotherapy).

Practice Questions (3-5 single-best-answer)

Question 1: A 45-year-old woman presents with a new lump in her breast. Which of the following is the most likely diagnosis?

A) Ductal carcinoma in situ (DCIS) B) Inflammatory breast cancer C) Fibroadenoma D) Phyllodes tumor

Answer: A) Ductal carcinoma in situ (DCIS)

Explanation: The patient's presentation of a new lump in her breast is most consistent with ductal carcinoma in situ (DCIS), a type of non-invasive breast cancer.

Question 2: A 65-year-old man presents with a cough and weight loss. Which of the following is the most likely diagnosis?

A) Adenocarcinoma B) Squamous cell carcinoma C) Small cell carcinoma D) Lymphoma

Answer: A) Adenocarcinoma

Explanation: The patient's presentation of a cough and weight loss is most consistent with adenocarcinoma, a type of non-small cell lung cancer.

Question 3: A 50-year-old woman presents with a change in bowel habits and rectal bleeding. Which of the following is the most likely diagnosis?

A) Adenocarcinoma B) Carcinoid tumor C) Lymphoma D) Gastrointestinal stromal tumor (GIST)

Answer: A) Adenocarcinoma

Explanation: The patient's presentation of a change in bowel habits and rectal bleeding is most consistent with adenocarcinoma, a type of colorectal cancer.

Quick Reference Card (60-Second Summary)

  • HER2-positive breast cancer-trastuzumab.
  • EGFR mutations-tyrosine kinase inhibitors.
  • Microsatellite instability-immunotherapy.
  • Surveillance imaging-CT, MRI, PET.
  • Tumor marker monitoring-PSA, CA-125.

If You Get Stuck on Test Day

  • Eliminate obviously wrong answers: Look for answers that are not consistent with the patient's presentation or diagnosis.
  • Use the "next best step" hierarchy: Start with the least invasive test (e.g., CBC) and move to more invasive tests (e.g., biopsy) as needed.
  • For Step 3 CCS: Order basic labs (e.g., CBC, LFTs), imaging studies (e.g., CT, MRI), and follow-up appointments.

Related USMLE Topics

  • Breast cancer connects to mastectomy, lumpectomy, chemotherapy.
  • Lung cancer connects to smoking cessation, chemotherapy, radiation therapy.
  • Colorectal cancer connects to colonoscopy, surgery, chemotherapy.